Cargando…
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study)
BACKGROUND: Second cancer is the leading cause of death in lymphoma survivors, with lung cancer representing the most common solid tumor. Limited information exists about the treatment and prognosis of second lung cancer following lymphoma. Herein, we evaluated the outcome and prognostic factors of...
Autores principales: | Fiorelli, Alfonso, D’Andrilli, Antonio, Carlucci, Annalisa, Vicidomini, Giovanni, Loizzi, Domenico, Ardò, Nicoletta Pia, Marasco, Rita Daniela, Ventura, Luigi, Ampollini, Luca, Carbognani, Paolo, Bocchialini, Giovanni, Lococo, Filippo, Paci, Massimiliano, Di Stefano, Teresa Severina, Ardissone, Francesco, Gagliasso, Matteo, Mendogni, Paolo, Rosso, Lorenzo, Mazzucco, Alessandra, Vanni, Camilla, Marinucci, Beatrice Trabalza, Potenza, Rossella, Matricardi, Alberto, Ragusa, Mark, Tassi, Valentina, Anile, Marco, Poggi, Camilla, Serra, Nicola, Sica, Antonello, Nosotti, Mario, Sollitto, Francesco, Venuta, Federico, Rendina, Erino Angelo, Puma, Francesco, Santini, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082280/ https://www.ncbi.nlm.nih.gov/pubmed/32206557 http://dx.doi.org/10.21037/tlcr.2019.12.28 |
Ejemplares similares
-
Pulmonary Hamartoma Associated With Lung Cancer (PHALC Study): Results of a Multicenter Study
por: Fiorelli, Alfonso, et al.
Publicado: (2021) -
Surgical treatment of lung cancer with adjacent lobe invasion in relation to fissure integrity
por: Andreetti, Claudio, et al.
Publicado: (2019) -
Linezolid-induced black hairy tongue
por: Cesare, Braggio, et al.
Publicado: (2018) -
Stenting treatment is a minimally traumatic and effective alternative to surgical repair for iatrogenic tracheobronchial lesion
por: D’Andrilli, Antonio, et al.
Publicado: (2020) -
Commentary: Extended resection for radical treatment of advanced-stage thymoma can result in resolution of severe myasthenia crisis refractory to medical therapy
por: D'Andrilli, Antonio, et al.
Publicado: (2020)